On November 4-6, Aistė Jekabsone, CEO of Exolitus, will attend BIO-Europe 2024 in Stockholm, Sweden, a premier partnering event that unites the global life science ecosystem.
At Exolitus, we specialize in the manufacture of extracellular particles (EPs), which are essential for developing advanced medicinal products. These powerful biological particles are leading the way in breakthroughs related to targeted therapies and innovative treatments.
Join us at BIO-Europe to explore EP-based innovations and discuss potential collaborations.To facilitate discussions, you can schedule a one-to-one meeting with Aistė Jekabsone.
Meetings can be arranged through the conference platform, or you may connect with Aistė directly on LinkedIn here, or reach out to us at info@exolitus.com. We look forward to the opportunity to drive innovation together in the life sciences sector.